Clearstead Advisors’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124K | Buy |
1,192
+60
| +5% | +$6.26K | ﹤0.01% | 998 |
|
|
2025
Q1 | $132K | Sell |
1,132
-250
| -18% | -$29.2K | ﹤0.01% | 921 |
|
|
2024
Q4 | $117K | Buy |
1,382
+50
| +4% | +$4.23K | ﹤0.01% | 981 |
|
|
2024
Q3 | $120K | Hold |
1,332
| – | – | ﹤0.01% | 982 |
|
|
2024
Q2 | $107K | Buy |
1,332
+32
| +2% | +$2.58K | ﹤0.01% | 982 |
|
|
2024
Q1 | $98.3K | Sell |
1,300
-50
| -4% | -$3.78K | ﹤0.01% | 613 |
|
|
2023
Q4 | $107K | Sell |
1,350
-1,350
| -50% | -$107K | 0.01% | 569 |
|
|
2023
Q3 | $189K | Buy |
2,700
+1,350
| +100% | +$94.4K | 0.01% | 576 |
|
|
2023
Q2 | $97K | Hold |
1,350
| – | – | 0.01% | 583 |
|
|
2023
Q1 | $83.3K | Hold |
1,350
| – | – | 0.01% | 544 |
|
|
2022
Q4 | $104K | Hold |
1,350
| – | – | 0.01% | 489 |
|
|
2022
Q3 | $60K | Hold |
1,350
| – | – | 0.01% | 574 |
|
|
2022
Q2 | $52K | Hold |
1,350
| – | – | ﹤0.01% | 607 |
|
|
2022
Q1 | $56K | Buy |
1,350
+300
| +29% | +$12.4K | ﹤0.01% | 653 |
|
|
2021
Q4 | $40K | Hold |
1,050
| – | – | ﹤0.01% | 688 |
|
|
2021
Q3 | $35K | Hold |
1,050
| – | – | ﹤0.01% | 664 |
|
|
2021
Q2 | $71K | Hold |
1,050
| – | – | 0.01% | 506 |
|
|
2021
Q1 | $59K | Buy |
1,050
+50
| +5% | +$2.81K | ﹤0.01% | 521 |
|
|
2020
Q4 | $81K | Hold |
1,000
| – | – | 0.01% | 449 |
|
|
2020
Q3 | $71K | Buy |
+1,000
| New | +$71K | 0.01% | 414 |
|